期刊文献+

血清Ⅰ型胶原吡啶交联终肽对肿瘤骨转移的早期诊断效能、疗效观察及预后价值的分析 被引量:1

The value of serum ICTP in the early diagnosis, efficacy and prognosis of tumor bone metastasis
原文传递
导出
摘要 目的 探讨检测血清Ⅰ型胶原吡啶交联终肽(ICTP)在肿瘤骨转移的早期诊断效能、疗效观察及预后价值.方法 选取336例肿瘤患者,依据核素骨显像(ECT)、MRI、X线等检查结果,结合临床分为骨转移组(180例)和未转移组(156例),并对其中60例骨转移者(治疗组)治疗前后的ICTP比较分析 另选60名健康体检者为健康对照组,应用酶免疫技术(EUSA)测定各组血清ICTP水平.将未转移组中61例血清ICTP高于正常值的患者行正电子发射断层成像或X线计算机断层成像(PET/CT)检查,未发现骨转移者,每半年1次进行ECT随访并同时检测ICTP,为期2年.结果 ①骨转移组血清ICTP[(10.47±7.56)μg/L]显著高于未转移组[(5.12±2.33)μg/L](t=9.503,P=0.000)和健康对照组[(2.76±0.62)μg/L](t=13.691,P=0.000).②未转移组中61例血清ICTP高于正常值者,ICTP为(5.98±1.95)μg/L,经PET/CT检查发现骨转移22例,余39例经2年随访发生骨转移26例,ICTP由(5.92±1.61)μg/L上升至(8.73±3.11)μg/L(t=4.612,P=0.000).③治疗有效者血清ICTP较治疗前下降,从(13.22±4.65)μg/L降至(7.18±3.54)μg/L(t=10.076,P=0.000),且疗效越显著,下降越明显.结论 血清ICTP能用于肿瘤骨转移的早期辅诊、筛查和疗效观察,并可监测骨转移的发生及预后判断. Objective To evaluate the serum pyridinoline cross-linked carboxyteminal telopeptide of type Ⅰ collagen ( ICTP) in the early diagnosis potency,efficacy and prognosis of tumor bone metastasis. Methods According to emission computed tomography(ECT) ,MRI and X-ray results,336 cases of tumor were divided into higher ICTP (5. 98 ± 1. 95μg/L ) than normal values. Twenty-two cases were identified bone metastasis through PET/CT examination. 26 cases were identified bone the effective cases decreased from( 13. 22 ± 4.65)μg/L (before treatment) to (7. 18 ±3. 54)μg/L (after treatment) (t = 10. 076,P = 0. 000). Conclusions Serum ICTP is helpful for the early diagnosis, screening and efficacy evaluation of tumor bone metastasis. It could be used for monitoring the occurrence of tumor bone metastasis and its prognosis.
出处 《中国综合临床》 2010年第7期679-682,共4页 Clinical Medicine of China
基金 基金项目:浙江省嘉兴市科技计划项目(2009BY7007)
关键词 Ⅰ型胶原吡啶交联终肽 肿瘤 骨转移 诊断效能 疗效观察 预后评估 ICTP Tumor Bone metastasis Diagnostic potency Efficacy Evaluation of prognosis
  • 相关文献

参考文献7

二级参考文献112

  • 1李钧,张楠,孔凡英,孙玉萍.唑来膦酸治疗恶性肿瘤骨转移研究进展[J].癌症进展,2005,3(5):486-489. 被引量:11
  • 2林奇,周士福.抗肿瘤血管生成和细胞凋亡研究进展[J].实用肿瘤学杂志,2004,18(5):397-400. 被引量:1
  • 3胡永成,马宏庆.全国骨转移瘤治疗专题座谈会会议纪要[J].中华骨科杂志,2003,23(6):323-325. 被引量:19
  • 4张新涛,徐栋梁,谭本前,胡俊勇,李佛保.转移性骨肿瘤897例临床分析[J].中国骨肿瘤骨病,2005,4(3):135-138. 被引量:31
  • 5刘子君 李瑞宗 等.骨肿瘤及瘤样病变12404例病理统计分析[J].中华骨科杂志,1986,16(3):162-169.
  • 6[1]Manabe J. Treatment modalities for metastatic bone tumors and associated issues:focusing on surgical indications and techniques for metastatic lesions in limb bones. J Orthop Sci ,2000,5:524 -531.
  • 7[2]Uchida A, Wakabayashi H, Okuyama N, et al. Metastatic bone disease:pathogenesis and new strategies for treatment. J Orthop Sci,2004,9:415 -920.
  • 8[5]Conroy T,Malissard L, Dartois D,et al. Natural history and development of bone metastasis: Apropos of 429 cases. Bull Cancer, 1988,75:845 - 857.
  • 9[6]Scutellari PN, Antinolfi G, Galeotti R, et al. Metastatic bone disease:Strategies for imaging. Minerva Med,2003,94:77 -90.
  • 10[8]Rougraff BT. Evaluation of the patient with carcinoma of unknown origin metastatic to bone. Clin Orthop,2003 ,415 :105 - 109.

共引文献88

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部